NYSE:SQZ

SQZ Biotechnologies (SQZ) Stock Price, News & Analysis

SQZ Biotechnologies logo
$0.02 0.00 (0.00%)
As of 11/17/2026

About SQZ Biotechnologies Stock (NYSE:SQZ)

Advanced

Key Stats

Today's Range
$0.02
▼
$0.02
50-Day Range
$0.02
▼
$0.02
52-Week Range
$0.25
▼
$3.56
Volume
5 shs
Average Volume
455,220 shs
Market Capitalization
$707.78 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SQZ Biotechnologies was a U.S.-based biotechnology company that developed cell therapies using its proprietary Cell Squeeze platform. The technology uses microfluidic devices to briefly deform cells, allowing therapeutic materials to enter them without relying on viral delivery methods.

The company’s research focused on harnessing the immune system to treat cancer and other diseases. Its clinical programs included experimental cell therapies designed to generate immune responses against cancers associated with human papillomavirus (HPV).

In late 2023, SQZ Biotechnologies filed for Chapter 11 bankruptcy protection and began winding down its operations. Its description as a biotechnology company reflects its historical business activities.

AI Generated. May Contain Errors.

Receive SQZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SQZ Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SQZ Stock News Headlines

SQZ Biotechnologies Co.
Your father's savings lost half their value after 1971.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
Arsenal Yards attracts another life sciences tenant
SQZB SQZ Biotechnologies Company - Seeking Alpha
SQZ Biotechnologies Co Ordinary Shares
See More Headlines

SQZ Stock Analysis - Frequently Asked Questions

SQZ Biotechnologies' stock was trading at $0.0240 at the beginning of 2026. Since then, SQZ shares have increased by 0.0% and is now trading at $0.0240.

SQZ Biotechnologies (NYSE:SQZ) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($8.00) EPS for the quarter, missing analysts' consensus estimates of ($5.60) by $2.40. The company had revenue of $4.76 million for the quarter, compared to the consensus estimate of $11.64 million. SQZ Biotechnologies had a negative net margin of 369.96% and a negative trailing twelve-month return on equity of 119.83%.

SQZ Biotechnologies's stock reverse split on Friday, July 7th 2023.The 1-10 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

SQZ Biotechnologies (SQZ) raised $75 million in an initial public offering (IPO) on Friday, October 30th 2020. The company issued 4,400,000 shares at $16.00-$18.00 per share. BofA Securities and Stifel acted as the underwriters for the IPO and BTIG was co-manager.

Shares of SQZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SQZ Biotechnologies investors own include Adicet Bio (ACET), Agenus (AGEN), Aldeyra Therapeutics (ALDX), Allogene Therapeutics (ALLO), Athersys (ATHX), Atossa Genetics (ATOS) and Atea Pharmaceuticals (AVIR).

Company Calendar

Today
11/18/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NYSE:SQZ
CIK
1604477
Fax
N/A
Employees
1,620
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($2.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$79.46 million
Net Margins
-369.96%
Pretax Margin
-408.99%
Return on Equity
-119.83%
Return on Assets
-59.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.50
Quick Ratio
3.50

Sales & Book Value

Annual Sales
$18.16 million
Price / Sales
0.04
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.94 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
29,491,000
Free Float
24,772,000
Market Cap
$707.78 thousand
Optionable
Not Optionable
Beta
2.34

Social Links

The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

This page (NYSE:SQZ) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners